Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-38,590
Closed -$3.76M 1094
2024
Q1
$3.76M Sell
38,590
-450
-1% -$39.4K 0.01% 628
2023
Q4
$3.22M Sell
39,040
-10,960
-22% -$734K 0.01% 648
2023
Q3
$3.2M Buy
+50,000
New +$3.47M 0.01% 625
2023
Q2
Sell
-29,600
Closed -$1.71M 1113
2023
Q1
$1.71M Buy
+29,600
New +$1.68M 0.01% 790
2022
Q1
Sell
-25,100
Closed -$1.51M 1207
2021
Q4
$1.51M Buy
25,100
+17,500
+230% +$945K ﹤0.01% 895
2021
Q3
$333K Buy
+7,600
New +$364K ﹤0.01% 1125
2021
Q1
Sell
-113,800
Closed -$3.47M 1256
2020
Q4
$3.47M Hold
113,800
0.01% 765
2020
Q3
$2.74M Buy
113,800
+900
+0.8% +$22K 0.01% 760
2020
Q2
$2.78M Sell
112,900
-1,100
-1% -$21K 0.01% 758
2020
Q1
$1.79M Sell
114,000
-21,400
-16% -$507K 0.01% 758
2019
Q4
$3.67M Buy
+135,400
New +$3.97M 0.01% 700

Other funds holding GMS

Axa's GMS Position: Q2 2024 in Review

Axa sold out of GMS Inc (GMS) in Q2 2024, closing a stake of 38,590 shares — an estimated $3.76M sold.

Axa first reported a position in GMS in Q4 2019 and held it in 11 quarters. The position peaked at $3.76M in Q1 2024. 289 funds tracked by Wall St. Rank hold GMS as of Q2 2024.

  • Axa reported no remaining GMS Inc position as of Q2 2024 after selling out during the quarter.
  • Axa sold 38,590 GMS Inc shares in Q2 2024, an estimated $3.76M.
  • Axa first reported a position in GMS Inc in Q4 2019 and held it in 11 quarters.
  • Axa's GMS Inc position peaked at $3.76M in Q1 2024.
  • 289 funds tracked by Wall St. Rank held GMS Inc as of Q2 2024.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.